US National Institutes of Health (NIH) to fund deoxyribonucleic (DNA) sequencing research:
This article was originally published in Clinica
The US NIH proposes to allocate discretionary funding to support new research in three areas: developing DNA sequencing technology; preparing a map of the rat genome; and techniques for small-angle X-ray scattering and spectroscopy. Congress has approved a discretionary fund amounting to 1% of the total NIH budget for the 1995 fiscal year beginning October 1st, according to Nature (May 25th). The NIH currently spends $135 million annually on external and $61 million on internal research in gene therapy.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.